A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(533 sites)

United States

Southern Cancer Center, PC, Daphne, Alabama

Ironwood Cancer and Research Centers, Chandler, Arizona

Banner MD Anderson Cancer Center, Gilbert, Arizona

Mayo Clinic, Scottsdale, Arizona

Arizona Clinical Research Center, Inc., Tucson, Arizona